Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (161-170 of 271) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry|January 12, 2010
beta-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: improvement of solubility by disruption of molecular planarityYuji Fujita, Mitsuhiro Yonehara, Masashi Tetsuhashi, et al.
Bioorganic & Medicinal Chemistry|March 18, 2008
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural developmentKosuke Dodo, Atsushi Aoyama, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry|September 17, 2010
Improvement of water-solubility of biarylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ-selective partial agonists by disruption of molecular planarity/symmetryJun-ichi Kasuga, Minoru Ishikawa, Mitsuhiro Yonehara, et al.
Bioorganic & Medicinal Chemistry|April 4, 2019
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeletonShun Nanjyo, Kenji Ohgane, Hiromasa Yoshioka, et al.
The Journal of Biological Chemistry|February 3, 2004
The Gtx homeodomain transcription factor exerts neuroprotection using its homeodomainYuichi Hashimoto, Osahiko Tsuji, Kohsuke Kanekura, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonistKeisuke Maruyama, Masaharu Nakamura, Shusuke Tomoshige, et al.
Scientific Reports|June 17, 2021
Improvement in aqueous solubility of achiral symmetric cyclofenil by modification to a chiral asymmetric analogJunki Morimoto, Kazunori Miyamoto, Yuki Ichikawa, et al.
Bioorganic & Medicinal Chemistry|April 8, 2014
Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligandYuko Nishiyama, Masahiko Nakamura, Takashi Misawa, et al.
The Journal of Investigative Dermatology|February 27, 2009
Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytesAi Yokoyama, Makoto Makishima, Mihwa Choi, et al.
Chemical & Pharmaceutical Bulletin|September 3, 2003
Cyclooxygenase inhibitors derived from thalidomideMamiko Suizu, Yohei Muroya, Hiroki Kakuta, et al.
Pageof 28

Showing results (161-170 of 271) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry|January 12, 2010
beta-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: improvement of solubility by disruption of molecular planarityYuji Fujita, Mitsuhiro Yonehara, Masashi Tetsuhashi, et al.
Bioorganic & Medicinal Chemistry|March 18, 2008
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural developmentKosuke Dodo, Atsushi Aoyama, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry|September 17, 2010
Improvement of water-solubility of biarylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ-selective partial agonists by disruption of molecular planarity/symmetryJun-ichi Kasuga, Minoru Ishikawa, Mitsuhiro Yonehara, et al.
Bioorganic & Medicinal Chemistry|April 4, 2019
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeletonShun Nanjyo, Kenji Ohgane, Hiromasa Yoshioka, et al.
The Journal of Biological Chemistry|February 3, 2004
The Gtx homeodomain transcription factor exerts neuroprotection using its homeodomainYuichi Hashimoto, Osahiko Tsuji, Kohsuke Kanekura, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonistKeisuke Maruyama, Masaharu Nakamura, Shusuke Tomoshige, et al.
Scientific Reports|June 17, 2021
Improvement in aqueous solubility of achiral symmetric cyclofenil by modification to a chiral asymmetric analogJunki Morimoto, Kazunori Miyamoto, Yuki Ichikawa, et al.
Bioorganic & Medicinal Chemistry|April 8, 2014
Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligandYuko Nishiyama, Masahiko Nakamura, Takashi Misawa, et al.
The Journal of Investigative Dermatology|February 27, 2009
Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytesAi Yokoyama, Makoto Makishima, Mihwa Choi, et al.
Chemical & Pharmaceutical Bulletin|September 3, 2003
Cyclooxygenase inhibitors derived from thalidomideMamiko Suizu, Yohei Muroya, Hiroki Kakuta, et al.
Pageof 28